[The pharmacokinetics and metabolism of a new choleretic, 3-ethyl-4-oxo-5-piperidino-   2,  -thiazolidineacetic acid ethyl ester (Piprozolin) after enteral administration in the rat].
D000085:Acetates / Q000097:blood / Q000378:metabolism / Q000652:urine; D000284:Administration, Oral; D000818:Animals; D001646:Bile / Q000378:metabolism; D002247:Carbon Isotopes; D002756:Cholagogues and Choleretics / Q000097:blood / Q000378:metabolism* / Q000652:urine; D004064:Digestive System / Q000378:metabolism; D005021:Ethylamines / Q000097:blood / Q000652:urine; D005243:Feces / Q000032:analysis; D007659:Ketones; D007700:Kinetics; D008297:Male; D010880:Piperidines / Q000097:blood / Q000378:metabolism* / Q000652:urine; D051381:Rats; D013844:Thiazoles / Q000097:blood / Q000378:metabolism* / Q000652:urine
D000085:Acetates; D002247:Carbon Isotopes; D002756:Cholagogues and Choleretics; D005021:Ethylamines; D007659:Ketones; D010880:Piperidines; D013844:Thiazoles
Zur Pharmakokinetik und zum Metabolismus des neuen Choleretikums 3-Athyl-4-oxo-5-piperidino-  2,  -thiazolidin-essigsäureäthylester (Piprozolin) nach enteraler Applikation an Ratten.